サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Metagenomic Sequencing Market Research Report- Forecast to 2023

メタゲノム解析市場調査レポート‐2023年までの予測

レポート概要

メタゲノム解析市場調査レポート:技術別(シーケンシング、バイオインフォマティクス)、用途別(感染症診断、環境修復、腸内細菌の特性評価、バイオテクノロジー、バイオ燃料、エコロジー、農業)‐2023年までの予測

市場シナリオ

メタゲノム解析は環境またはコミュニティ・ゲノミクスとも呼ばれ、特定の宿主微生物のDNAがその微生物から直接採取されクローン化されるゲノム研究のことを言います。遺伝子検査は多額の費用が掛かる上、特殊なインフラや資源を必要とします。現在、遺伝子検査市場は主に北米と西ヨーロッパで広く行われています。サービスプロバイダーや企業がその検査を手頃な価格で可能にし、拡大が見込まれる世界の未開発地域に参入する機会は非常に多くあります。検査コストが低減された場合は多くの人が遺伝子検査を受ける可能性があります。

遺伝子疾患に対する認知度の向上が世界のメタゲノム解析市場をけん引しています。先進的技術プラットフォームや改善されたゲノム解析ツールがこの市場の成長を促す主な要因です。さらに、先進的バイオインフォマティクスツール、新薬の復帰、ハイスループット・スクリーニング法、次世代シーケンシングなどの費用対効果の高い技術の開発などもこの市場の成長を押し上げています。

また、新しい抗生物質や酵素を発見するための研究開発活動の強化や改善されたバイオインフォマティクスによって主要プレイヤーにとって魅力的な事業機会をもたらします。一方で、診断検査の標準化と精度に関する懸念の高まりや知識の不足が抑制要因となります。

レポート詳細

目次

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation

Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis

Chapter 6. Global Metagenomic sequencing Market, by Technology
6.1 Introduction
6.2 Sequencing
6.2.1 Market Estimates & Forecast, 2016 - 2023
6.3 Bioinformatics
6.3.1 Market Estimates & Forecast, 2016 - 2023
6.4 Others

Chapter 7. Global Metagenomic sequencing Market, by Application
7.1 Introduction
7.2 Infectious disease diagnosis
7.2.1 Market Estimates & Forecast, 2017 - 2023
7.3 Environmental remediation
7.3.1 Market Estimates & Forecast, 2017 - 2023
7.4 Gut microbe characterization
7.4.1 Market Estimates & Forecast, 2017 - 2023
7.5 Biotechnology
7.5.1 Market Estimates & Forecast, 2017 - 2023
7.6 Biofuel
7.6.1 Market Estimates & Forecast, 2017 - 2023
7.7 Ecology
7.7.1 Market Estimates & Forecast, 2017 - 2023
7.8 Agriculture
7.8.1 Market Estimates & Forecast, 2017 - 2023
7.9 Others

Chapter 8. Global Metagenomic sequencing Market, by End User
8.1 Introduction
8.2 Hospitals
8.2.1 Market Estimates & Forecast, 2017 - 2023
8.3 Ambulatory Surgical Centers
8.3.1 Market Estimates & Forecast, 2017 - 2023
8.4 Specialized Clinics
8.4.1 Market Estimates & Forecast, 2017 - 2023
8.5 Others

Chapter. 9 Global Metagenomic sequencing Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 U.K
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Rest of the Middle East & Africa

Chapter 10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments

Chapter 11 Company Profiles
11.1 GATC Biotech AG
11.1.1 Company Overview
11.1.2 Application Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Enterome Bioscience
11.2.1 Company Overview
11.2.2 Application Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Illumina Inc.
11.3.1 Company Overview
11.3.2 Application Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Quest Diagnostics
11.4.1 Company Overview
11.4.2 Applications/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 F Hoffman-La Roche Ltd.
11.5.1 Company Overview
11.5.2 Application Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.6 Thermo Fisher Scientific Inc.
11.6.1 Company Overview
11.6.2 Application Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 CLC Bio
11.7.1 Overview
11.7.2 Application Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Agilent Technologies Inc.
11.8.1 Company Overview
11.8.2 Applications/Business Segment Overview
11.8.3 Financial Overview
11.8.4 Key Development
11.8.5 SWOT Analysis
11.9 Macrogen Inc.
11.9.1 Company Overview
11.9.2 Application Overview
11.9.3 Financial overview
11.9.4 Key Developments
11.10 Helicos BioSciences
11.10.1 Company Overview
11.10.2 Application Overview
11.10.3 Financial overview
11.10.4 Key Developments
11.11 Others

Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Pharmaceutical industry

Chapter 13 Appendix

LIST OF TABLES
Table 1 Metagenomic sequencing Industry Synopsis, 2017 - 2023
Table 2 Metagenomic sequencing Market Estimates and Forecast, 2017 - 2023, (USD Million)
Table 3 Metagenomic sequencing Market by Region, 2017 - 2023, (USD Million)
Table 4 Metagenomic sequencing Market by Technology, 2017 - 2023, (USD Million)
Table 5 Metagenomic sequencing Market by Applications, 2017 - 2023, (USD Million)
Table 6 Metagenomic sequencing Market by End Users, 2017 - 2023, (USD Million)
Table 7 North America Metagenomic sequencing Market by Technology, 2017 - 2023, (USD Million)
Table 8 North America Metagenomic sequencing Market by Applications, 2017 - 2023, (USD Million)
Table 9 North America Metagenomic sequencing Market by End User, 2017 - 2023, (USD Million)
Table 10 US Metagenomic sequencing Market by Technology, 2017 - 2023, (USD Million)
Table 11 US Metagenomic sequencing Market by Applications, 2017 - 2023, (USD Million)
Table 12 US Metagenomic sequencing Market by End User, 2017 - 2023, (USD Million)
Table 13 Canada Metagenomic sequencing Market by Technology, 2017 - 2023, (USD Million)
Table 14 Canada Metagenomic sequencing Market by Applications, 2017 - 2023, (USD Million)
Table 15 Canada Metagenomic sequencing Market by End User, 2017 - 2023, (USD Million)
Table 16 South America Metagenomic sequencing Market by Technology, 2017 - 2023, (USD Million)
Table 17 South America Metagenomic sequencing Market by Applications, 2017 - 2023, (USD Million)
Table 18 South America Metagenomic sequencing Market by End User, 2017 - 2023, (USD Million)
Table 19 Europe Metagenomic sequencing Market by Technology, 2017 - 2023, (USD Million)
Table 20 Europe Metagenomic sequencing Market by Applications, 2017 - 2023, (USD Million)
Table 21 Europe Metagenomic sequencing Market by End User, 2017 - 2023, (USD Million)
Table 22 Western Europe Metagenomic sequencing Market by Technology, 2017 - 2023, (USD Million)
Table 23 Western Europe Metagenomic sequencing Market by Applications, 2017 - 2023, (USD Million)
Table 24 Western Europe Metagenomic sequencing Market by End User, 2017 - 2023, (USD Million)
Table 25 Eastern Europe Metagenomic sequencing Market by Technology, 2017 - 2023, (USD Million)
Table 26 Eastern Europe Metagenomic sequencing Market by Applications, 2017 - 2023, (USD Million)
Table 27 Eastern Europe Metagenomic sequencing Market by End User, 2017 - 2023, (USD Million)
Table 28 Asia Pacific Metagenomic sequencing Market by Technology, 2017 - 2023, (USD Million)
Table 29 Asia Pacific Metagenomic sequencing Market by Applications, 2017 - 2023, (USD Million)
Table 30 Asia Pacific Metagenomic sequencing Market by End User, 2017 - 2023, (USD Million)
Table 31 The Middle East & Africa Metagenomic sequencing Market by Technology, 2017 - 2023, (USD Million)
Table 32 The Middle East & Africa Metagenomic sequencing Market by Applications, 2017 - 2023, (USD Million)
Table 33 The Middle East & Africa Metagenomic sequencing Market by End User, 2017 - 2023, (USD Million)

LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Metagenomic sequencing Market
Figure 3 Segmentation Market Dynamics for Metagenomic sequencing Market
Figure 4 Global Metagenomic sequencing Market Share, by Technology 2016
Figure 5 Global Metagenomic sequencing Market Share, by Application2016
Figure 6 Global Metagenomic sequencing Market Share, by End Users, 2016
Figure 7 Global Metagenomic sequencing Market Share, by Region, 2016
Figure 8 North America Metagenomic sequencing Market Share, by Country, 2016
Figure 9 Europe Metagenomic sequencing Market Share, by Country, 2016
Figure 10 Asia Pacific Metagenomic sequencing Market Share, by Country, 2016
Figure 11 The Middle East & Africa Metagenomic sequencing Market Share, by Country, 2016
Figure 12 Global Metagenomic sequencing Market: Company Share Analysis, 2016 (%)
Figure 13 GATC Biotech AG: Key Financials
Figure 14 GATC Biotech AG: Segmental Revenue
Figure 15 GATC Biotech AG: Geographical Revenue
Figure 16 Enterome Bioscience: Key Financials
Figure 17 Enterome Bioscience: Segmental Revenue
Figure 18 Enterome Bioscience: Geographical Revenue
Figure 19 Illumina Inc.: Key Financials
Figure 20 Illumina Inc.: Segmental Revenue
Figure 22 Illumina Inc.: Geographical Revenue
Figure 23 Quest Diagnostics: Key Financials
Figure 24 Quest Diagnostics: Segmental Revenue
Figure 25 Quest Diagnostics: Geographical Revenue
Figure 27 F Hoffman-La Roche Ltd.: Key Financials
Figure 28 F Hoffman-La Roche Ltd.: Segmental Revenue
Figure 29 F Hoffman-La Roche Ltd.: Geographical Revenue
Figure 30 Thermo Fisher Scientific Inc.: Key Financials
Figure 32 Thermo Fisher Scientific Inc.: Segmental Revenue
Figure 33 Thermo Fisher Scientific Inc.: Geographical Revenue
Figure 33 Tornier N.V.: Key Financials
Figure 34 Tornier N.V.: Segmental Revenue
Figure 35 Tornier N.V.: Geographical Revenue
Figure 36 Össur: Key Financials
Figure 37 Össur: Segmental Revenue
Figure 38 Össur: Geographical Revenue
Figure 39 Acumed, LLC: Key Financials
Figure 40 Acumed, LLC: Segmental Revenue
Figure 41 Acumed, LLC: Geographical Revenue

発刊日

2018/11

体裁

PDF / 90ページ

販売価格

4,450USD

発行

Market Research Future

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

バイオ・ゲノム・再生医療

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE